Article
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients.
Journal of clinical laboratory analysis - 1 Jan 2001
Quiros-Roldan E, Moretti F, Airoldi M, Fausti C, Chiodera A, Castelli F, Carosi G
Abstract excerpt
Multiple nucleoside resistance involves specific genetic changes in the HIV-1 reverse transcriptase gene, such as Q151M mutation and an insertion of two serine aminoacids at RT codon 69. Among 432 patients failing antiretroviral therapy, five (1.15%) harboured viruses with Q151M mutation into the RT gene and no viruses were identified harbouring insertion at codon 69. Also we have studied the long-term benefit of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
